Intellia Therapeutics Announces Second Quarter 2019 Financial Results and Company Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to  Intellia Therapeutics Announces Second Quarter 2019 Financial Results and Company Update

Intellia Therapeutics (NTLA) Tops Q2 EPS by 4c, Revenues Beat

August 1, 2019 7:45 AM EDT

Intellia Therapeutics (NASDAQ: NTLA) reported Q2 EPS of ($0.56), $0.04 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $11.11 million versus the consensus estimate of $7.11 million.

We continue to build our in vivo and engineered cell therapy pipeline in support of... More